Clinical trial
STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia
NCT00376467 · Gruppo Italiano Malattie EMatologiche dell'Adulto, Other · Completed
Key facts
| NCT number | NCT00376467 |
|---|---|
| Title | STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia |
| Official title | STI 571 (GLIVEC) in the Treatment of Philadelphia-chromosome Positive and/or BCR/ABL Rearranged Adult Acute Lymphoblastic Leukemia. GIMEMA LAL 0201. |
| Lead sponsor | Gruppo Italiano Malattie EMatologiche dell'Adulto, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia |
| Intervention type | Drug |
| Interventions | Imatinib |
| Enrollment | 105 |
| Start date | Dec 1, 2001 |
| Primary completion | Jun 1, 2010 |
| Completion | Feb 1, 2011 |
| First posted | Sep 14, 2006 |
| Last update posted | Feb 7, 2014 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: